This paper describes our challenging for produsing pulmonary functional imaging in nuclear medicine, magnetic resonance (MR) and computed tomography fields in our institute of Yamaguchi University School of Medicine. These pulmonary functional imaging include [99m]Tc-hexamethy-propyleneamine (HMPAO) and N-isopropyl-p-[123]I-iodoamphetamine (IMP) scintigraphies, [123]I-metaiodobenzylguuanidine (MIBG) scintigraphies, pulmonary [133]Xenon gas dynamic SPECT, respiratory-gated or breath-hold [99m]Tc-Technegas venilation/ macroaggregated albumin (MAA) perfusion SPECT, non-contrast ECG-gated perfusion MR imaging and gadolinium-diethlene-triamine pentaacetic acid (Gd-DTPA) aerosol ventilation MR imaging, and pulmonary interstitial (magnetic resonance) MR/computed tomographic (CT) lymphographies. These functional imaging can be expected to contribute to the understanding of functional impairment or treatment strategy in lung diseases.
pulmonary function
pulmonary perfusion
computed tomography (CT)
magnetic resonance (MR) imaging
single photon emission computed tomography (SPECT)